Target type: biologicalprocess
The directed import of D-aspartate from the extracellular region across the plasma membrane and into the cytosol. [PMID:7914198]
D-aspartate import across the plasma membrane is a crucial process for cellular function, involving the uptake of D-aspartate, a non-proteinogenic amino acid, from the extracellular environment into the cell. This transport is facilitated by specific membrane proteins known as D-aspartate transporters. These transporters act as gateways, selectively binding to D-aspartate molecules and mediating their passage across the hydrophobic barrier of the plasma membrane.
The precise mechanism of D-aspartate transport varies depending on the specific transporter involved. However, in general, these transporters operate through a process called facilitated diffusion, where the movement of D-aspartate is driven by its concentration gradient. This means that D-aspartate flows from an area of high concentration outside the cell to an area of lower concentration inside the cell, following the laws of thermodynamics.
The transport process typically involves the following steps:
1. Binding: D-aspartate molecules bind to the transporter protein on the extracellular side of the plasma membrane.
2. Conformational Change: The binding of D-aspartate induces a conformational change in the transporter protein, opening a pathway for the amino acid to cross the membrane.
3. Translocation: D-aspartate moves through the transporter protein into the intracellular space.
4. Release: Once inside the cell, D-aspartate dissociates from the transporter protein, allowing the transporter to return to its initial conformation and bind another molecule of D-aspartate.
D-aspartate import has significant biological implications. It plays a role in various cellular processes, including:
- Neurotransmission: D-aspartate is a potential neurotransmitter in the central nervous system, influencing neuronal activity and synaptic plasticity.
- Cell Signaling: D-aspartate can activate intracellular signaling pathways, leading to changes in gene expression and cellular behavior.
- Immune Function: D-aspartate has been implicated in immune responses, modulating the activity of immune cells.
- Hormonal Regulation: D-aspartate may affect hormone production and secretion, particularly in the endocrine system.
The regulation of D-aspartate transport is tightly controlled, ensuring an appropriate balance of D-aspartate levels within the cell. Factors influencing D-aspartate transport include:
- Substrate Concentration: The concentration of D-aspartate outside the cell influences the rate of transport.
- Transporter Expression: The number of transporter proteins on the cell membrane affects the overall transport capacity.
- Cellular Metabolism: The metabolic pathways that utilize D-aspartate inside the cell can influence the rate of import.
- Physiological Conditions: Factors such as pH, temperature, and the presence of other molecules can influence the activity of D-aspartate transporters.
In conclusion, D-aspartate import across the plasma membrane is a complex and tightly regulated process with significant biological implications. It involves the selective transport of D-aspartate into the cell by specialized membrane proteins, driven by its concentration gradient and influenced by various cellular and environmental factors. Understanding this process is crucial for comprehending the role of D-aspartate in cellular function, signaling, and organismal health.'
"
Protein | Definition | Taxonomy |
---|---|---|
Excitatory amino acid transporter 3 | An excitatory amino acid transporter 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P43005] | Homo sapiens (human) |
Excitatory amino acid transporter 2 | An excitatory amino acid transporter 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P43004] | Homo sapiens (human) |
Excitatory amino acid transporter 1 | An excitatory amino acid transporter 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P43003] | Homo sapiens (human) |
Neurotensin receptor type 1 | A neurotensin receptor type 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P30989] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies. | non-proteinogenic alpha-amino acid | |
cysteine | cysteine; cysteine zwitterion; L-alpha-amino acid; proteinogenic amino acid; serine family amino acid | EC 4.3.1.3 (histidine ammonia-lyase) inhibitor; flour treatment agent; human metabolite | |
aspartic acid | aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter. L-aspartic acid : The L-enantiomer of aspartic acid. | aspartate family amino acid; aspartic acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; mouse metabolite; neurotransmitter |
d-glutamate | D-alpha-amino acid; glutamic acid | Escherichia coli metabolite; mouse metabolite | |
glutamic acid | glutamic acid : An alpha-amino acid that is glutaric acid bearing a single amino substituent at position 2. Glutamic Acid: A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM. | glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical |
d-aspartic acid | aspartic acid; D-alpha-amino acid | mouse metabolite | |
sym 2081 | |||
dihydrokainate | dicarboxylic acid | ||
sr 48692 | SR 48692: structure in first source; a neurotensin receptor-1 antagonist | N-acyl-amino acid | |
serine o-sulfate | L-serine O-sulfate : A non-proteinogenic L-alpha-amino acid that is the O-sulfo derivative of L-serine. serine O-sulfate: RN given refers to (L)-isomer | L-serine derivative; non-proteinogenic L-alpha-amino acid; O-sulfoamino acid | |
hinokinin | hinokinin : A lignan that is dihydrofuran-2(3H)-one (gamma-butyrolactone) substituted by a 3,4-methylenedioxybenzyl group at positions 3 and 4 (the 3R,4R-diastereoisomer). hinokinin: suppresses expression of both HBsAg and HBeAg | benzodioxoles; gamma-lactone; lignan | trypanocidal drug |
3-hydroxyaspartic acid, (threo-l)-isomer | (3S)-3-hydroxy-L-aspartic acid : The (3S)-diastereomer of 3-hydroxy-L-aspartic acid. | 3-hydroxy-L-aspartic acid | metabolite |
2-amino-3-phenylmethoxybutanedioic acid | aspartic acid derivative | ||
l-ccg iii | |||
dl-threo-beta-benzyloxyaspartate | |||
neurotensin | |||
sr 142948 | SR 142948: structurally similar to SR-48692 | N-acyl-amino acid | |
ceftriaxone | 1,2,4-triazines; 1,3-thiazoles; cephalosporin; oxime O-ether | antibacterial drug; drug allergen; EC 3.5.2.6 (beta-lactamase) inhibitor | |
sr 48527 | SR 48527: SR 48527 is the S-enantiomer; SR-49711 is the R-enantiomer | ||
sr 142948a | SR 142948A: structure in first source | ||
4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl)-piperidine hydrogen chloride | |||
l-beta-threo-benzyl-aspartate | L-beta-threo-benzyl-aspartate: structure in first source | ||
neurotensin | neurotensin, Tyr(11)-: RN given refers to parent cpd & (D)-isomer; RN for cpd without isomeric designation not avail 5/91 | peptide hormone | human metabolite; mitogen; neurotransmitter; vulnerary |
ucph 101 | 2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile: structure in first source | ||
nitd 609 | NITD 609: an antimalarial and coccidiostat; structure in first source |